Lv11
74 积分 2021-08-23 加入
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
3小时前
待确认
Unveiling the Mechanism of Lurbinectedin's Action and Its Potential in Combination Therapies in Small Cell Lung Cancer
3小时前
已完结
Emerging therapies for opioid-induced constipation: what can we expect?
1个月前
已完结
Pathophysiology, diagnosis, and management of opioid-induced constipation
1个月前
已完结
Polymeric micellar paclitaxel (Pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis
3个月前
已完结
Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
3个月前
已完结
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China
3个月前
已完结
Polymeric micellar paclitaxel (Pm-Pac) prolonged overall survival for NSCLC patients without pleural metastasis
3个月前
已完结
Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer
5个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
5个月前
已完结
皖公网安备34019202002308
